PD-L1阴性NSCLC患者免疫治疗策略疗效比较数据集

资源简介

PD-L1阴性NSCLC患者免疫治疗策略疗效比较数据集

【一句话概览】

本数据集是 figshare 公开的结构化表格数据集，收录 2 个文件、合计 915.54 KB，主题涵盖 Immune checkpoint inhibitors、negative PD-L1 expression、NSCLC、overall survival、Progression-free survival，可用于统计建模、特征工程与队列分析，CC BY 4.0 许可开放获取。

【数据集背景】

本数据集源站标题为《Efficacy comparison of immune treating strategies for NSCLC patients with negative PD-L1 expression》。配套论文《Efficacy comparison of immune treating strategies for NSCLC patients with negative PD-L1 expression》发表于 Expert Review of Clinical Immunology（2022），DOI：10.1080/1744666X.2022.2088510。项目资助方：This research was supported by the Hunan Provincial Natural Science Foundation of China (No. 2020JJ5951, No. 2021JJ80079), the Youth Science Foundation of Xiangya Hospital (No. 2019Q17), the Degree & Postgraduate Education Reform Project of Central South University (No. 2021YJSKSA10), the Undergraduate Education Reform Project of Central South University (No. 2021CG065, No. 2021CG068) and the Research Project of Laboratory Construction and Management of Central South University (No. 202120).。源站首次发布：2022-06-15。

【数据内容】

源站原始描述：We intended to compare and grade the proposed immune treating strategies for non-small cell lung cancer (NSCLC) with negative Programmed Cell Death Ligand 1(PD-L1). We compared the efficacy of single immune checkpoint inhibitor (ICI), single ICI plus chemotherapy, and doublet ICIs with chemotherapy alone, as well as single ICI plus radiotherapy with single ICI for negative PD-L1 (We included 23 randomized control trials with 4665 patients. Compared with chemotherapy alone, single ICI, single ICI…

【数据结构与技术规格】

文件数 2 个，合计 915.54 KB。ierm_a_2088510_sm1581.docx：application/vnd.openxmlformats-officedocument.wordprocessingml.document，899.79 KB。ierm_a_2088510_sm1578.docx：application/vnd.openxmlformats-officedocument.wordprocessingml.document，15.75 KB。数据集 DOI：10.6084/m9.figshare.20071677.v1。

【主题与分类】

源站学科分类：Medicine、Microbiology、Molecular Biology、Pharmacology、Immunology、Mathematical Sciences not elsewhere classified。主题标签：Immune checkpoint inhibitors、negative PD-L1 expression、NSCLC、overall survival、Progression-free survival。

【适用方向】

结构化表格数据可直接用于统计建模、特征工程与队列分析。

【获取与许可】

源站页面：https://tandf.figshare.com/articles/dataset/Efficacy_comparison_of_immune_treating_strategies_for_NSCLC_patients_with_negative_PD-L1_expression/20071677

使用许可：CC BY 4.0（https://creativecommons.org/licenses/by/4.0/）。

规范引用：Efficacy comparison of immune treating strategies for NSCLC patients with negative PD-L1 expression. Taylor & Francis. Ding, Kaiyue; Yi, Minhan; Liang, Hui; Li, Zhongkui; Zhang, Yuan

【使用注意】

· 源站最后修改于 2024-02-12，引用时请注意版本时效。